Hospitalisation costs of malignant mesothelioma: results from the Italian hospital discharge registry (2001-2018).

ABSTRACT:

Objectives

This paper aims to establish hospitalisation costs of mesothelioma in Italy and to evaluate hospital-related trends associated with the 1992 asbestos ban.

Design

This is a retrospective population-based study of Italian hospitalisations treating pleura, peritoneum and pericardium mesothelioma in the period 2001-2018.

Settings

Public and private Italian hospitals reached by the Ministry of Health (coverage close to 100%).

Participants

157 221 admissions with primary or contributing diagnosis of pleural, peritoneal or hearth cancer discharged from 2001 to 2018.Primary and secondary outcome measures: number, length and cost of hospitalisations with related percentages.

Results

Each year, Italian hospitals treated a mesothelioma in 6025 admissions

SUBMITTER: Ferrante P 

PROVIDER: S-EPMC8354284 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature